Teladoc Health (TDOC) Receivables (2014 - 2026)

Teladoc Health (TDOC) has 13 years of Receivables data on file, last reported at $222.5 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables fell 8.51% year-over-year to $222.5 million; the trailing twelve-month figure through Mar 2026 stood at $222.5 million (down 8.51% YoY), and the FY2025 full-year result was $201.7 million, down 9.96% from the prior year.
• Receivables improved to $222.5 million in Q1 2026, from $201.7 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $243.2 million in Q1 2025 to a low of $201.7 million in Q4 2025.
• A 5-year average of $226.3 million and a median of $227.3 million in 2022 frame the typical range for Receivables.
• Across the five-year window, Receivables advanced 27.01% in 2022 and declined 9.96% in 2025, its largest moves.
• Tracing TDOC's Receivables over 5 years: stood at $235.6 million in 2022, then declined by 2.37% to $230.1 million in 2023, then declined by 2.65% to $224.0 million in 2024, then decreased by 9.96% to $201.7 million in 2025, then gained by 10.35% to $222.5 million in 2026.
• Business Quant data shows TDOC's Receivables at $222.5 million in Q1 2026, $201.7 million in Q4 2025, and $219.5 million in Q3 2025.